MEGHAN TOBICZYK: Open Payments
NPI 1275768392 · BERKLEY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,295 in 62 payments from 14 companies in 2025. Trend: 2023 $343 · 2024 $1,084 · 2025 $1,295
Food & beverage: $1,247Education: $48
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 16 | $263 |
| GENZYME CORPORATION | 10 | $216 |
| ABBVIE INC. | 10 | $174 |
| Regeneron Healthcare Solutions, Inc. | 4 | $125 |
| E.R. Squibb & Sons, L.L.C. | 6 | $122 |
| Janssen Biotech, Inc. | 3 | $98 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| Incyte Corporation | 2 | $55 |
| ConvaTec Inc. | 1 | $39 |
| Organon LLC | 1 | $33 |
Products named: DUPIXENT, NEMLUVIO, Sotyktu, SKYRIZI, TREMFYA, COSENTYX, RINVOQ, OPZELURA.
Industry payments across MI — which companies pay providers there.
